STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
Reported by STAT News · all stories from statnews.com
Editorial digest
The leader of the FDA's digital health division has announced that regulatory guidance for generative artificial intelligence tools is forthcoming. This will clarify how the agency plans to oversee this rapidly advancing technology.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/3/2026
STAT+: FDA, CMS look to collaborate with states on health AI
Federal regulators at the FDA and CMS plan to partner with state authorities regarding medical artificial intelligence.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom11/5/2026
STAT+: What the midterms could mean for the future of health AI
Upcoming midterm election outcomes could reshape regulatory policies and federal oversight for medical artificial intelligence technologies.
- Trusted health newsroom10/30/2026
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Federal health agencies are working quickly to prevent oversight bottlenecks as states prepare clinical artificial intelligence trials.
- Trusted health newsroom10/6/2026
STAT+: FDA spells out 2027 AI guidance plans
The FDA has detailed its plans for AI guidelines in 2027.
- Trusted health newsroom10/7/2026
STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
Utah's healthcare artificial intelligence trials may conflict with federal regulatory bodies.
